Additional Resources
Top Commentators:
- Elliott Abrams
- Fouad Ajami
- Shlomo Avineri
- Benny Avni
- Alan Dershowitz
- Jackson Diehl
- Dore Gold
- Daniel Gordis
- Tom Gross
- Jonathan Halevy
- David Ignatius
- Pinchas Inbari
- Jeff Jacoby
- Efraim Karsh
- Mordechai Kedar
- Charles Krauthammer
- Emily Landau
- David Makovsky
- Aaron David Miller
- Benny Morris
- Jacques Neriah
- Marty Peretz
- Melanie Phillips
- Daniel Pipes
- Harold Rhode
- Gary Rosenblatt
- Jennifer Rubin
- David Schenkar
- Shimon Shapira
- Jonathan Spyer
- Gerald Steinberg
- Bret Stephens
- Amir Taheri
- Josh Teitelbaum
- Khaled Abu Toameh
- Jonathan Tobin
- Michael Totten
- Michael Young
- Mort Zuckerman
Think Tanks:
- American Enterprise Institute
- Brookings Institution
- Center for Security Policy
- Council on Foreign Relations
- Heritage Foundation
- Hudson Institute
- Institute for Contemporary Affairs
- Institute for Counter-Terrorism
- Institute for Global Jewish Affairs
- Institute for National Security Studies
- Institute for Science and Intl. Security
- Intelligence and Terrorism Information Center
- Investigative Project
- Jerusalem Center for Public Affairs
- RAND Corporation
- Saban Center for Middle East Policy
- Shalem Center
- Washington Institute for Near East Policy
Media:
- CAMERA
- Daily Alert
- Jewish Political Studies Review
- MEMRI
- NGO Monitor
- Palestinian Media Watch
- The Israel Project
- YouTube
Government:
Back
(JTA) Benjamin Brafman - Israel has made disproportionately large contributions to the fight against cancer. A breakthrough in the 1980s by Israeli scientist Eli Canaani was critical to the development of Gleevec, a drug that has saved the lives of millions diagnosed with leukemia. Velcade, a drug used to treat bone marrow cancer, was based on the research of Israeli professors Avram Hershko and Aaron Ciechanover, and their collaborator Irwin Rose, who went on to win the Nobel Prize for chemistry in 2004. Israeli scientists discovered the role that mutations in the p53 gene play in causing cancerous tumors, and how a minor mutation in the RAD51 gene increases the risk of breast cancer in women with the BRCA2 gene mutation. It was scientists at the Hebrew University of Jerusalem and Hadassah Medical Center who contributed to the platform science that resulted in the development of Doxil, the first drug encapsulated in a microscopic fat bubble for direct delivery to a tumor site.2017-11-17 00:00:00Full Article
Israeli Scientists Have Helped Develop Life-Saving Cancer Drugs
(JTA) Benjamin Brafman - Israel has made disproportionately large contributions to the fight against cancer. A breakthrough in the 1980s by Israeli scientist Eli Canaani was critical to the development of Gleevec, a drug that has saved the lives of millions diagnosed with leukemia. Velcade, a drug used to treat bone marrow cancer, was based on the research of Israeli professors Avram Hershko and Aaron Ciechanover, and their collaborator Irwin Rose, who went on to win the Nobel Prize for chemistry in 2004. Israeli scientists discovered the role that mutations in the p53 gene play in causing cancerous tumors, and how a minor mutation in the RAD51 gene increases the risk of breast cancer in women with the BRCA2 gene mutation. It was scientists at the Hebrew University of Jerusalem and Hadassah Medical Center who contributed to the platform science that resulted in the development of Doxil, the first drug encapsulated in a microscopic fat bubble for direct delivery to a tumor site.2017-11-17 00:00:00Full Article
Search Daily Alert
Search:
|